AstraZeneca set to announce drug price deal with Trump administration - Bloomberg
PositiveFinancial Markets

AstraZeneca is poised to announce a significant drug price deal with the Trump administration, which could lead to lower medication costs for millions of Americans. This agreement is crucial as it reflects ongoing efforts to make healthcare more affordable and accessible, especially in a time when many are struggling with high prescription prices. The collaboration between a major pharmaceutical company and the government could set a precedent for future negotiations in the industry.
— Curated by the World Pulse Now AI Editorial System